Home > Financial Ratios > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Core EBITDA Margin

    Back to All Ratios
TATVA CHINTAN PHARMA CHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results

TATVA CHINTAN PHARMA CHEM Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 17.3314.3425.0122.1721.00

What is the latest Core EBITDA Margin ratio of TATVA CHINTAN PHARMA CHEM ?

The latest Core EBITDA Margin ratio of TATVA CHINTAN PHARMA CHEM is 17.33 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202417.33
Mar202314.34
Mar202225.01
Mar202122.17
Mar202021.00

How is Core EBITDA Margin of TATVA CHINTAN PHARMA CHEM Trending?

Years Core EBITDA Margin % Change
Mar2024 17.33
20.85
Mar2023 14.34
-42.66
Mar2022 25.01
12.81
Mar2021 22.17
5.57
Mar2020 21 -

Other Financial Ratios of TATVA CHINTAN PHARMA CHEM


Compare Core EBITDA Margin ratio of peers of TATVA CHINTAN PHARMA CHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM ₹1,794.9 Cr 5.5% 17.7% -34.4% Stock Analytics
PIDILITE INDUSTRIES ₹158,253.0 Cr 5.2% 5.8% 9.4% Stock Analytics
SOLAR INDUSTRIES INDIA ₹125,581.0 Cr 4.8% 26.3% 56% Stock Analytics
SRF ₹85,237.0 Cr -2.2% 5% 27.6% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹42,402.6 Cr -1.8% 5% 20.4% Stock Analytics
GODREJ INDUSTRIES ₹37,884.6 Cr 5.3% 5.4% 36.1% Stock Analytics


TATVA CHINTAN PHARMA CHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

5.5%

17.7%

-34.4%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses